Mather Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$544K Sell
1,274
-102
-7% -$41.8K ﹤0.01% 524
2026
Q2
$537K Sell
1,376
-57
-4% -$24.1K ﹤0.01% 518
2026
Q1
$678K Buy
1,433
+98
+7% +$49.3K 0.01% 421
2025
Q4
$623K Buy
1,335
+36
+3% +$16.7K 0.01% 364
2025
Q3
$554K Sell
1,299
-60
-4% -$23.3K 0.01% 385
2025
Q2
$521K Sell
1,359
-1
-0.1% -$360 0.01% 382
2025
Q1
$470K Buy
1,360
+222
+20% +$71.4K 0.01% 394
2024
Q4
$342K Sell
1,138
-70
-6% -$24.5K ﹤0.01% 441
2024
Q3
$491K Buy
1,208
+341
+39% +$125K 0.01% 367
2024
Q2
$289K Buy
867
+58
+7% +$18.8K ﹤0.01% 541
2024
Q1
$219K Sell
809
-18
-2% -$5.5K ﹤0.01% 506
2023
Q4
$224K Buy
+827
New +$204K ﹤0.01% 519
2023
Q3
– Sell
-740
Closed -$225K – 570
2023
Q2
$225K Buy
+740
New +$206K ﹤0.01% 523

Other funds holding HCA

Mather Group's HCA Position: Q3 2026 in Review

Mather Group reduced its HCA Healthcare (HCA) stake by 7.4% in Q3 2026, selling an estimated $41.8K and leaving 1,274 shares worth $544K. The position accounts for ﹤0.01% of the portfolio, ranked #524.

Mather Group first reported a position in HCA in Q2 2023 and has held it in 13 quarters since. The position peaked at $678K in Q1 2026. 348 funds tracked by Wall St. Rank hold HCA as of Q3 2026.

  • Mather Group held 1,274 shares of HCA Healthcare worth $544K as of Q3 2026.
  • Mather Group sold 102 HCA Healthcare shares in Q3 2026, an estimated $41.8K.
  • HCA Healthcare made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #524 holding.
  • Mather Group first reported a position in HCA Healthcare in Q2 2023 and has held it in 13 quarters since.
  • Mather Group's HCA Healthcare position peaked at $678K in Q1 2026.
  • 348 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.